Anzeige
Mehr »
Donnerstag, 14.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0MLEC | ISIN: US09065A1007 | Ticker-Symbol:
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOLARGO INC Chart 1 Jahr
5-Tage-Chart
BIOLARGO INC 5-Tage-Chart

Aktuelle News zur BIOLARGO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
BIOLARGO Aktie jetzt für 0€ handeln
05.05.BioLargo, Inc: BioLargo Subsidiary Clyra Medical Signs Exclusive Distribution Agreement with Al- Hikma FZCO for ViaCLYR Across the Middle East, North Africa, and Adjacent Markets292Agreement Extends Clyra's International Reach Through One of the Region's Premier Healthcare Distributors WESTMINSTER, CA / ACCESS Newswire / May 5, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and...
► Artikel lesen
04.05.BIOLARGO, INC. - 8-K, Current Report-
04.05.BioLargo, Inc: BioLargo Signs Memorandum of Understanding with Aquatech to Accelerate Commercialization of PFAS Treatment Technology267WESTMINSTER, CA / ACCESS Newswire / May 4, 2026 / BioLargo Equipment Solutions & Technologies, Inc. ("BioLargo Equipment"), a subsidiary of BioLargo, Inc. (OTCQX:BLGO), an environmental engineering...
► Artikel lesen
04.05.BioLargo, Inc: BioLargo to Participate in a Town Hall Meeting Hosted by the BioLargo Shareholder Community on Discord on May 5, 2026218A meeting transcript will be published by 8-K prior to the market open the next day WESTMINSTER, CA / ACCESS Newswire / May 4, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences innovator...
► Artikel lesen
20.04.BioLargo, Inc: BioLargo Engineering, Science & Technologies Awarded $1.2 Million Contract to Design Pilot-Scale Minerals Processing Facility for Resource Recovery316WESTMINSTER, CA / ACCESS Newswire / April 20, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator focused on sustainable water and environmental solutions, announced that its engineering subsidiary...
► Artikel lesen
09.04.BIOLARGO, INC. - S-1, General form for registration of securities-
01.04.BioLargo, Inc: BioLargo CEO Dennis Calvert to Present Global Environmental Leadership Award to Robert Bilott at Nassau County PFAS Forum327BioLargo sponsors legal and technical forum on PFAS contamination; company's PFAS remediation technology to be featured on a technical panel alongside leading environmental engineering firms, followed...
► Artikel lesen
25.03.BIOLARGO, INC. - 8-K, Current Report1
06.03.BioLargo reports FY results1
05.03.BioLargo anticipates 2026 as a transformative year with Clyra Medical commercialization and battery joint ventures1
05.03.BIOLARGO, INC. - 8-K, Current Report2
05.03.Earnings Call Transkript: BioLargo Q4 2025 Ergebnisse zeigen gemischte Signale1
05.03.BioLargo, Inc: BioLargo Reports Annual 2025 Operating and Financial Results541A Year of Disciplined Execution as BioLargo Gained Commercialization for Several Business Segments with $3.9 Million Cash Balance at Year End WESTMINSTER, CALIFORNIA / ACCESS Newswire / March 5, 2026...
► Artikel lesen
04.03.BIOLARGO, INC. - 10-K, Annual Report1
04.03.BioLargo, Inc: BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern Time355WESTMINSTER, CALIFORNIA / ACCESS Newswire / March 4, 2026 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will...
► Artikel lesen
18.02.BioLargo, Inc.: BioLargo Subsidiary Clyra Medical Highlights Key Opinion Leader Presentation of Exceptional ViaCLYR Clinical Results at Leading Wound Care Symposium258Clinical Experience Presented at Boswick Symposium Shows Rapid Wound Transformation, Enhanced Healing, and Strong Antimicrobial Performance Across Multiple Wound Types WESTMINSTER, CALIFORNIA / ACCESS...
► Artikel lesen
09.02.BioLargo, Inc.: BioLargo Subsidiary Clyra Medical Technologies Secures First Stocking Order with Advanced Solution for ViaCLYR Wound Irrigation Solution334Initial Distribution Launch Marks Transition to Revenue-Generating Operations WESTMINSTER, CALIFORNIA / ACCESS Newswire / February 9, 2026 / BioLargo, Inc. (OTCQX:BLGO), a cleantech and life sciences...
► Artikel lesen
27.01.BioLargo, Inc: BioLargo Installs AEC PFAS Treatment System at Lake Stockholm, New Jersey358WESTMINSTER, CALIFORNIA / ACCESS Newswire / January 27, 2026 / BioLargo, Inc. (OTCQX:BLGO) today announced that its patented Aqueous Electrostatic Concentrator (AEC) PFAS treatment system has been installed...
► Artikel lesen
16.01.BioLargo, Inc: BioLargo to Present at Sidoti's Micro-Cap Virtual Conference on Thursday January 22nd at 1pm EST388WESTMINSTER, CA / ACCESS Newswire / January 16, 2026 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve challenging environmental and cleantech...
► Artikel lesen
29.12.25BioLargo, Inc.: BioLargo Reflects on 2025 Progress and Positions for the Next Phase of Global Infrastructure, Environmental, and Medical Innovation456WESTMINSTER, CALIFORNIA / ACCESS Newswire / December 29, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator focused on sustainable water and environmental solutions, announced that it had delivered...
► Artikel lesen
Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1